PERGAMID
Dead / Cancelled — Cancelled — Section 8 (as of 15 Dec 2000)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74057883
- Registration number
- 1805066
- Mark type
- Word mark
- Filed
- 11 May 1990
- Published for opposition
- 16 Jun 1992
- Registered
- 16 Nov 1993
- Attorney of record
- E. Scott Johnson
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation used in the treatment of bone marrow of cancer patients
Owner
- Nova Pharmaceutical Corporation, Baltimore, MD, US
- Nova Pharmaceutical Corporation, Baltimore, MD, US
- Nova Pharmaceutical Corporation, Baltimore, MD, US
Prosecution history
- 15 Dec 2000 — CANCELLED SEC. 8 (6-YR)
- 16 Nov 1993 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 1993 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jul 1993 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jul 1993 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Feb 1993 — NON-FINAL ACTION MAILED
- 10 Nov 1992 — ASSIGNED TO EXAMINER
- 03 Nov 1992 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Oct 1992 — USE AMENDMENT FILED
- 08 Sept 1992 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jun 1992 — PUBLISHED FOR OPPOSITION
- 15 May 1992 — NOTICE OF PUBLICATION
- 21 Feb 1992 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 1992 — EXAMINER'S AMENDMENT MAILED
- 16 Apr 1991 — CORRESPONDENCE RECEIVED IN LAW OFFICE